Literature DB >> 26200919

Inhibitors of sphingosine-1-phosphate metabolism (sphingosine kinases and sphingosine-1-phosphate lyase).

Pol Sanllehí1, José-Luis Abad2, Josefina Casas2, Antonio Delgado3.   

Abstract

Sphingolipids (SLs) are essential structural and signaling molecules of eukaryotic cells. Among them, sphingosine 1 phosphate (S1P) is a recognized promoter of cell survival, also involved, inter alia, in inflammation and tumorigenesis processes. The knowledge and modulation of the enzymes implicated in the biosynthesis and degradation of S1P are capital to control the intracellular levels of this lipid and, ultimately, to determine the cell fate. Starting with a general overview of the main metabolic pathways involved in SL metabolism, this review is mainly focused on the description of the most relevant findings concerning the development of modulators of S1P, namely inhibitors of the enzymes regulating S1P synthesis (sphingosine kinases) and degradation (sphingosine 1 phosphate phosphatase and lyase). In addition, a brief overview of the most significant agonists and antagonists at the S1P receptors is also addressed.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Enzymes; Inhibitors; Metabolism; Modulators; Sphingolipid

Mesh:

Substances:

Year:  2015        PMID: 26200919     DOI: 10.1016/j.chemphyslip.2015.07.007

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  12 in total

Review 1.  Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection.

Authors:  Irina V Tiper; James E East; Priyanka B Subrahmanyam; Tonya J Webb
Journal:  Pathog Dis       Date:  2016-06-27       Impact factor: 3.166

2.  New fluorogenic probes for neutral and alkaline ceramidases.

Authors:  Mireia Casasampere; Núria Bielsa; Daniel Riba; Laura Bassas; Ruijuan Xu; Cungui Mao; Gemma Fabriàs; José-Luis Abad; Antonio Delgado; Josefina Casas
Journal:  J Lipid Res       Date:  2019-03-29       Impact factor: 5.922

Review 3.  Orm/ORMDL proteins: Gate guardians and master regulators.

Authors:  Deanna Davis; Muthukumar Kannan; Binks Wattenberg
Journal:  Adv Biol Regul       Date:  2018-08-31

Review 4.  Targeting Sphingosine Kinases for the Treatment of Cancer.

Authors:  Clayton S Lewis; Christina Voelkel-Johnson; Charles D Smith
Journal:  Adv Cancer Res       Date:  2018-06-09       Impact factor: 6.242

5.  Scintillation Proximity Assay to Detect the Changes in Cellular Dihydrosphingosine 1-Phosphate Levels.

Authors:  Mamoru Ohtoyo; Masakazu Tamura; Nobuo Machinaga; Fumihito Muro; Ryuji Hashimoto
Journal:  Lipids       Date:  2016-09-02       Impact factor: 1.880

6.  SPHK1 promotes metastasis of thyroid carcinoma through activation of the S1P/S1PR3/Notch signaling pathway.

Authors:  Zhijing Zhao; Junfeng Ma; Baoquan Hu; Yi Zhang; Shushu Wang
Journal:  Exp Ther Med       Date:  2018-04-12       Impact factor: 2.447

Review 7.  Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair.

Authors:  Ziad Sartawi; Ernestina Schipani; Katie B Ryan; Christian Waeber
Journal:  Pharmacol Res       Date:  2017-09-22       Impact factor: 7.658

8.  Sphingosine-1-Phosphate Lyase Inhibition Alters the S1P Gradient and Ameliorates Crohn's-Like Ileitis by Suppressing Thymocyte Maturation.

Authors:  Thangaraj Karuppuchamy; Christopher J Tyler; Luke R Lundborg; Tamara Pérez-Jeldres; Abigail K Kimball; Eric T Clambey; Paul Jedlicka; Jesús Rivera-Nieves
Journal:  Inflamm Bowel Dis       Date:  2020-01-06       Impact factor: 7.290

9.  Arachnoid membrane as a source of sphingosine-1-phosphate that regulates mouse middle cerebral artery tone.

Authors:  Francesc Jiménez-Altayó; Julia Marzi; María Galan; Ana Paula Dantas; Marisa Ortega; Santiago Rojas; Gustavo Egea; Katja Schenke-Layland; Elena Jiménez-Xarrié; Anna M Planas
Journal:  J Cereb Blood Flow Metab       Date:  2021-09-02       Impact factor: 6.960

10.  Verification of the Necessity of the Tolyl Group of PF-543 for Sphingosine Kinase 1 Inhibitory Activity.

Authors:  Su Bin Kim; Taeho Lee; Hong Seop Moon; Sung Hwan Ki; Yoon Sin Oh; Joo-Youn Lee; Sang-Bum Kim; Jeong-Eun Park; Yongseok Kwon; Sanghee Kim; Dong Jae Baek; Eun-Young Park
Journal:  Molecules       Date:  2020-05-27       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.